Dargistotug
Dargistotug (M-6223) is a fully human IgG1 monoclonal antibody targeting TIGIT (T cell immune receptor with Ig domain and ITIM) . TIGIT is an inhibitory immune checkpoint that promotes NK cell depletion and reduces the secretion of cytokines by binding to CD155 and other antibodies. It can also directly or indirectly inhibit effector T cells and upregulate Tregs cells, thereby exerting immunosuppression. Function[1].
Product Specifications
CAS Number
2649362-29-6
Product Name Alternative
M-6223
UNSPSC
12352203
Target
Transmembrane Glycoprotein
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/dargistotug.html
Purity
99.36
Solubility
10 mM in DMSO
Smiles
[Dargistotug]
Molecular Weight
(1.47 kDa)
References & Citations
[1]Harjunpää H, Guillerey C. TIGIT as an emerging immune checkpoint. Clin Exp Immunol. 2020 May;200 (2) :108-119.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
![Upstream Binding Protein 1 (UBP1) Mouse Monoclonal Antibody [Clone ID: OTI7D3]](https://cdn.genprice.uk/products/937/68dd18ba061270361e908404/imageurl/cf808809.webp)
Upstream Binding Protein 1 (UBP1) Mouse Monoclonal Antibody [Clone ID: OTI7D3]
Cathepsin D (Tumor Marker) (CTSD/3083), CF740 conjugate, 0.1mg/mL
Human alpha smooth muscle Actin (ACTA2) activation kit by CRISPRa
